Bion®3 made its debut in Japan: The flagship product of the Merck Consumer Health Care division is now also available in the world’s second-largest market for prescription-free, over-the-counter drugs. It is the first product of its kind to combine probiotic cultures with multivitamins and minerals. Bion®3 is marketed by SATO Pharmaceutical, the sixth-largest consumer health care company in Japan. Bion®3 is already marketed in 30 countries around the world.